MX2012001667A - Extract of leaves of salix babylonica and leucaena leucocephalia in the treatment of parasitic diseases in sheep. - Google Patents

Extract of leaves of salix babylonica and leucaena leucocephalia in the treatment of parasitic diseases in sheep.

Info

Publication number
MX2012001667A
MX2012001667A MX2012001667A MX2012001667A MX2012001667A MX 2012001667 A MX2012001667 A MX 2012001667A MX 2012001667 A MX2012001667 A MX 2012001667A MX 2012001667 A MX2012001667 A MX 2012001667A MX 2012001667 A MX2012001667 A MX 2012001667A
Authority
MX
Mexico
Prior art keywords
sheep
extracts
leucocephalia
parasitic diseases
leucaena
Prior art date
Application number
MX2012001667A
Other languages
Spanish (es)
Other versions
MX336558B (en
Inventor
Abdel-Fattah Zeidan Mohamed Salem
Original Assignee
Univ Autonoma Del Estado De Mexico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Autonoma Del Estado De Mexico filed Critical Univ Autonoma Del Estado De Mexico
Priority to MX2012001667A priority Critical patent/MX336558B/en
Publication of MX2012001667A publication Critical patent/MX2012001667A/en
Publication of MX336558B publication Critical patent/MX336558B/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)

Abstract

The present invention refers to a pharmaceutical formulation that contains liquid extracts of S. babylonica, L. leucocephalia and the mixture of both extracts (1:1, v/v) for treating parasitic diseases in sheep, where the active agents are the metabolic compounds in tables 1, 2 and 3; and figures from 1 to 20. The process for obtaining said extracts attains a substantial increase in the concentration of the active compounds, additionally allowing liquid extracts to be prepared, which due to the transparent appearance thereof has a higher acceptance by sheep and is practical. The pharmaceutical formulation of the present invention produces an antihelmintic effect higher than the extracts reported in the state-of-the-art and without the side effects of the drugs currently used in the treatments of the parasitic disease in sheep.
MX2012001667A 2012-02-08 2012-02-08 Extract of leaves of salix babylonica and leucaena leucocephalia in the treatment of parasitic diseases in sheep. MX336558B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2012001667A MX336558B (en) 2012-02-08 2012-02-08 Extract of leaves of salix babylonica and leucaena leucocephalia in the treatment of parasitic diseases in sheep.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2012001667A MX336558B (en) 2012-02-08 2012-02-08 Extract of leaves of salix babylonica and leucaena leucocephalia in the treatment of parasitic diseases in sheep.

Publications (2)

Publication Number Publication Date
MX2012001667A true MX2012001667A (en) 2013-08-27
MX336558B MX336558B (en) 2016-01-25

Family

ID=49552879

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012001667A MX336558B (en) 2012-02-08 2012-02-08 Extract of leaves of salix babylonica and leucaena leucocephalia in the treatment of parasitic diseases in sheep.

Country Status (1)

Country Link
MX (1) MX336558B (en)

Also Published As

Publication number Publication date
MX336558B (en) 2016-01-25

Similar Documents

Publication Publication Date Title
AU2016202421B2 (en) Method of treating neurological conditions with cardiac glycosides
MX2015002239A (en) Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions.
IN2015DN00376A (en)
BR112015008447A2 (en) methods to treat cancer
WO2019199861A3 (en) Hemp extract for treatment of pain in animals
IN2012DN06720A (en)
EA201270221A1 (en) TREATMENT OF CROWN DISEASE WITH LACQUINIMODE
EA201590655A1 (en) COMBINATION OF LACHINIMODE AND PRIDOPIDINE FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
EA201400002A1 (en) METHODS TO TREAT DISEASES OF THE RETAIL
BR112014031394A2 (en) compositions and methods for transmucosal absorption
MX344476B (en) Methods of treating pulmonary disorders with liposomal amikacin formulations.
EA201390984A1 (en) HETEROCYCLIC COMPOUNDS SUITABLE FOR THE TREATMENT OF DYSLIPIDEMIA
MX2015013148A (en) Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics.
UA113962C2 (en) PHARMACEUTICAL COMPOSITION CONTAINING APOMORPHINE AS AN ACTIVE INGREDIENT
IN2014DN08440A (en)
MX2015015036A (en) Methods for improving lipid profiles using atrasentan.
CO7101244A2 (en) Substituted phenylimidazopyrazoles and their use
MX345675B (en) Method of treating neurological conditions with extract of nerium species or thevetia species.
MY180502A (en) Compound of glycosaminoglycan, preparation method and use thereof
IN2014MN02269A (en)
EA201691299A1 (en) APPLICATION OF LACHINIMODA TO SLOW DOWN THE PROGRESSION OF HANTINGTON'S DISEASE
NZ754328A (en) Marker for acid sphingomyelinase disorders and uses thereof
BR112014011336A2 (en) pharmaceutical compositions comprising 7- (1h-imidazol-4-ylmethyl) -5,6,7,8-tetrahydro-quinoline for treating skin conditions and conditions
MX2014014817A (en) Compounds for treating inflammation and pain.
MX336558B (en) Extract of leaves of salix babylonica and leucaena leucocephalia in the treatment of parasitic diseases in sheep.